The oncogenic fusionprotein NPM-ALK cooperates with Bcl2 to induce T-cell lymphomas in mice.

被引：0
|
作者：
Miething, Cornelius
Grundler, Rebekka
Mugler, Claudia
Bauer, Anette
Haecker, Georg
Peschel, Christian
Duyster, Justus
机构：
[1] Tech Univ Munich, Dept Hematol Oncol, D-8000 Munich, Germany
[2] Tech Univ Munich, Dept Microbiol, D-8000 Munich, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2058.2058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2058
引用
收藏
页码：583A / 583A
页数：1
相关论文
共 50 条
  • [1] NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
    Chiarle, R
    Gong, JZ
    Guasparri, I
    Pesci, A
    Cai, J
    Liu, J
    Simmons, WJ
    Dhall, G
    Howes, J
    Piva, R
    Inghirami, G
    BLOOD, 2003, 101 (05) : 1919 - 1927
  • [2] Towards Improved Models of NPM-ALK Induced T-Cell Lymphoma
    Ehrenfeld, Sophia
    Shoumariyeh, Khalid
    Poggio, Teresa
    Khan, Robin
    Redhaber, Desiree Melanie
    Kreutmair, Stefanie
    Klingeberg, Cathrin
    Illert, Anna Lena
    Duyster, Justus
    Miething, Cornelius
    BLOOD, 2018, 132
  • [3] NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
    Singh, Vijay Kumar
    Werner, Sebastian
    Schwalm, Simone
    Lennerz, Volker
    Ruf, Stephanie
    Stadler, Serena
    Hackstein, Holger
    Reiter, Alfred
    Woelfel, Thomas
    Damm-Welk, Christine
    Woessmann, Wilhelm
    ONCOIMMUNOLOGY, 2019, 8 (09):
  • [4] TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma
    Shi, Wenyu
    George, Suraj Konnath
    George, Bhawana
    Curry, Choladda V.
    Murzabdillaeva, Albina
    Alkan, Serhan
    Amin, Hesham M.
    MOLECULAR ONCOLOGY, 2017, 11 (09): : 1189 - 1207
  • [5] NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells
    Ambrogio, Chiara
    Martinengo, Cinzia
    Voena, Claudia
    Tondat, Fabrizio
    Riera, Ludovica
    di Celle, Paola Francia
    Inghirami, Giorgio
    Chiarle, Roberto
    CANCER RESEARCH, 2009, 69 (22) : 8611 - 8619
  • [6] Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase
    Turner, SD
    Tooze, R
    Maclennan, K
    Alexander, DR
    ONCOGENE, 2003, 22 (49) : 7750 - 7761
  • [7] Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase
    Suzanne D Turner
    Reuben Tooze
    Kenneth Maclennan
    Denis R Alexander
    Oncogene, 2003, 22 : 7750 - 7761
  • [8] Trka, a Novel Binding Partner of NPM-ALK Oncogenic Tyrosine Kinase, Facilitates the Survival of T-Cell Anaplastic Large-Cell Lymphoma
    Shi, Wenyu
    George, Suraj Konnath
    Curry, Choladda V.
    Alkan, Serhan
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [9] Sumoylation Sustains the Stability of NPM-ALK Oncogenic Protein and Facilitates Its Nuclear Accumulation in T-Cell Anaplastic Large-Cell Lymphoma
    Vishwamitra, Deeksha
    Curry, Choladda V.
    Alkan, Serhan
    Shi, Ping
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [10] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
    Shi, Ping
    Lai, Raymond
    Lin, Quan
    Iqbal, Abid S.
    Young, Leah C.
    Kwak, Larry W.
    Ford, Richard J.
    Amin, Hesham M.
    BLOOD, 2009, 114 (02) : 360 - 370
12345